Reuters logo
BRIEF-Celsion reports final clinical and translational research data from its ovation study
October 3, 2017 / 1:35 PM / 16 days ago

BRIEF-Celsion reports final clinical and translational research data from its ovation study

Oct 3 (Reuters) - Celsion Corp:

* Celsion Corp says announces final clinical and translational research data from its ovation study

* Celsion says data shows 86 pct objective response rate and 86% r0 & r1 surgical resection rate in all patients treated in four dose-escalating cohorts

* Celsion says data shows clear evidence of biological activity including dose dependent increases in inflammatory cytokines (il-12 and ifn-g)

* Celsion Corp - company expects to file a next phase protocol with FDA later this year in connection with the ovation study

* Celsion corp - company also held an advisory board meeting on september 27, 2017 to discuss safety data from ovation study Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below